For example, inhibiting palmitoylation of human GSDMD at the C191 site using the specific inhibitor NU 6300 effectively suppressed GSDMD cleavage in the human monocytic leukemia cell lines (Jiang et al., 2024b). Here, GSDMD is linked to monocytic leukemia.